Jump to content

Definition:Series B

From Insurer Brain

💰 Series B is a venture capital financing round that, within the insurtech industry, typically represents the stage at which a startup has validated its core product — whether an underwriting platform, a claims automation tool, or a distribution technology — and is raising capital to scale operations, expand into new markets, or deepen its carrier and broker partnerships. In the broader startup ecosystem, Series B sits between the product-market-fit stage of Series A and the pre-IPO growth stage of Series C, but in insurance the round carries particular significance because scaling in a regulated, relationship-driven industry demands substantial investment in compliance infrastructure, licensing, and trust-building with established market participants.

⚙️ A Series B round for an insurtech company generally involves institutional venture capital firms — often joined by strategic investors such as insurance carriers, reinsurers, or insurance-focused private equity funds — investing in exchange for preferred equity with negotiated governance and liquidation preferences. Round sizes in insurtech have varied widely depending on the business model: a full-stack MGA seeking to build its own loss reserves or secure capacity commitments may require significantly more capital than a pure software-as-a-service platform selling tools to incumbents. The due diligence process at Series B often scrutinizes insurance-specific metrics — loss ratios, gross written premium growth, combined ratios for risk-bearing insurtechs, or net revenue retention for technology vendors — alongside traditional software metrics like recurring revenue and customer acquisition cost. Strategic investors at this stage frequently bring more than capital: a reinsurer's participation, for example, may signal future capacity support, while a carrier investor may offer distribution access.

📌 The Series B stage often determines whether an insurtech company can achieve the scale necessary to become a durable participant in the insurance value chain or remains a niche experiment. Insurance is an industry where trust, regulatory standing, and long-term track records matter enormously — and Series B capital is what typically funds the transition from promising newcomer to credible counterparty. Companies that successfully navigate this round often use the proceeds to obtain additional licenses across jurisdictions, build out actuarial and compliance teams, and invest in the data infrastructure required for sophisticated risk modeling. The round also tends to set the valuation trajectory and investor expectations that shape the company's path toward later-stage funding, strategic acquisition, or public listing.

Related concepts: